Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 30 (CCDC30) is a protein encoded by the CCDC30 gene in humans. It contains a coiled-coil domain and belongs to the family of proteins related to the prefoldin subunit beta-like group, though its precise biological function is currently unknown[1][6][10]. CCDC30 has been cloned from fetal brain tissue, and while its expression has been documented, there is minimal experimental evidence regarding its molecular activity or physiological role[9][7]. Evidence associating CCDC30 with disease is sparse, but variants have been linked to dilated cardiomyopathy in some gene databases[5]. No drugs are currently reported to interact with CCDC30, and there is no established role for this protein as a drug target, biomarker, or therapeutic molecule[5][7][9]. Key attributes: - CCDC30 is a protein-coding gene present on human chromosome 1[9]. - Alternative names include prefoldin subunit 6-like protein, underscoring speculation about chaperone-like functions based on sequence homology[2][6]. - There is currently no experimental evidence in the literature or curated gene databases that defines a direct molecular function, biological process, or cellular component for this protein in mammals[7]. - No known interactions with drugs, nor a recognized role as a therapeutic target, have been recorded in public resources up to the current date[5][7][9]. - Its limited annotation and unknown function limit its classification; it is most accurately described as "Other" within the conventional molecular class system. If further research established clear biological function or therapeutic relevance, these fields would require update.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 30 (CCDC30).